- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/22 - Oxygen atoms attached in position 2 or 4
Patent holdings for IPC class C07D 215/22
Total number of patents in this class: 374
10-year publication summary
|
26
|
21
|
25
|
27
|
21
|
16
|
30
|
17
|
30
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Exelixis, Inc. | 395 |
45 |
| Alkermes Pharma Ireland Limited | 254 |
15 |
| Janssen Pharmaceutica N.V. | 3168 |
12 |
| Amgen Inc. | 4427 |
7 |
| Handa Oncology, LLC | 23 |
6 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 775 |
5 |
| Otsuka Pharmaceutical Co., Ltd. | 1502 |
5 |
| Alonbio Ltd. | 12 |
5 |
| Nippon Soda Co., Ltd. | 884 |
4 |
| Oregon Health & Science University | 754 |
4 |
| Synthon BV | 310 |
4 |
| Eisai R&D Management Co., Ltd. | 1167 |
4 |
| Tarapeutics Science Inc. | 26 |
4 |
| Bristol-myers Squibb Company | 4742 |
3 |
| Sandoz AG | 1412 |
3 |
| Vertex Pharmaceuticals Incorporated | 1582 |
3 |
| Active Biotech AB | 57 |
3 |
| Astellas Pharma Inc. | 1044 |
3 |
| Beijing Konruns Pharmaceutical Co., Ltd. | 19 |
3 |
| Emory University | 1719 |
3 |
| Other owners | 233 |